SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-02-003802
Filing Date
2002-11-14
Accepted
2002-11-14 17:18:19
Documents
3
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR NOVAVAX, INC. w65772e10vq.htm 10-Q 172792
3 CERTIFICATION BY INTERIM PRESIDENT & CEO w65772exv99w1.htm EX-99.1 2451
4 CERTIFICATION BY VICE PRESIDENT & CFO w65772exv99w2.htm EX-99.2 2701
  Complete submission text file 0000950133-02-003802.txt   179775
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 02826325
SIC: 2836 Biological Products, (No Diagnostic Substances)